Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia
- 24 May 2017
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (12)
Abstract
Maffucci syndrome is a nonhereditary disorder caused by somatic mosaic isocitrate dehydrogenase 1 or 2 (IDH1 or IDH2) mutations and is characterized by multiple enchondromas along with hemangiomas. Malignant transformation of enchondromas to chondrosarcomas and secondary neoplasms, such as brain tumors or acute myeloid leukemia, are serious complications. A 15‐year‐old female with Maffucci syndrome developed B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). A somatic mutation in IDH1 was detected in hemangioma and leukemic cells. KRAS mutation and deletion of IKZF1 were detected in leukemic cells. Patients with Maffucci syndrome may, therefore, be at risk of BCP‐ALL associated with secondary genetic events that affect lymphocyte differentiation.Keywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 15 references indexed in Scilit:
- Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescentsBlood, 2016
- Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working GroupEuropean Journal of Medical Genetics, 2016
- Inherited genetic variation in childhood acute lymphoblastic leukemiaBlood, 2015
- ( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are ReversibleScience, 2013
- Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2Nature Genetics, 2011
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeNature Genetics, 2011
- IDH1 and IDH2 mutations in pediatric acute leukemiaLeukemia, 2011
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationCancer Cell, 2010
- Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic valueBlood, 2010
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009